Home > Chemicals & Materials > Polymers > Medical Polymers > Polyglycerol Sebacate (PGS) Market

Polyglycerol Sebacate (PGS) Market Size

  • Report ID: GMI3101
  • Published Date: Sep 2024
  • Report Format: PDF

Polyglycerol Sebacate Market Size

The global polyglycerol sebacate market size was valued at USD 65.49 million in 2023 and is anticipated to grow at 10.6% CAGR from 2024 to 2032. Polyglycerol sebacate is a biocompatible and biodegradable polymer resin formed by polycondensation of sebacic acid (from castor oil) and glycerol. PGS is used as an elastomer in coating of bio textiles such as valves, meshes made up of polyethylene, polyester among others. It is most widely used in tissue engineering, especially for nerve and cardiovascular tissue regeneration applications.

 

It can also be extruded with some additives which can be used as a bone graft in joint replacement applications. Although the current market of PGS is very negligible and is under development phase, there exists a huge potential to replace other biomaterials such as polylactic acid, poly-L-lactic acid (PLLA), poly glycolic acid (PG), polycaprolactone (PCL) in future as PGS can mimic natural tissue in terms of flexibility. Also, it is soft in nature, robust and has low cost as compared to other biodegradable elastomers. Current applications of PGS elastomer include nerve guidance, tissue regeneration, blood vessel reconstruction, drug delivery among others.
 

The increasing demand for tissue engineering and regenerative medicine is driving significant interest in advanced biomaterials, including polyglycerol sebacate (PGS). PGS, known for its biocompatibility and customizable properties, is emerging as a key material in creating scaffolds and matrices for tissue regeneration. Its unique degradability and mechanical properties make it ideal for supporting cell growth and tissue repair.
 

Simultaneously, the growing need for biomedical textiles, which enhance the healing process, is further boosting the PGS market. Biomedical textiles, incorporating materials like PGS, are used in wound care, surgical implants, and other medical applications where rapid and effective healing is critical. The versatility of PGS in forming complex structures and its ability to interact favourably with biological tissues align well with these trends, positioning it as an asset in both tissue engineering and advanced medical textiles, thereby driving market growth.

Authors: Kiran Pulidindi, Manish Verma

Frequently Asked Questions (FAQ) :

The market size of polyglycerol sebacate reached USD 65.49 million in 2023 and is anticipated to grow at a 10.6% CAGR from 2024 to 2032.

The tissue engineering application segment held a 45% market share in 2023, amounting to USD 29.47 million, and is projected to grow at a 9% CAGR from 2024 to 2032.

The soft gel segment is projected to capture USD 43.35 million and demonstrate a 9.6% CAGR by 2032, due to their flexibility and biocompatibility, making them ideal for drug delivery systems and tissue scaffolding.

The North America market is projected to achieve USD 74.34 million, with a CAGR of 12% from 2024 to 2032, owing to a rise in the aging population and an increase in lifestyle diseases such as obesity.

Leading players in the market include BASF SE, Cambridge Polymers Group, Evonik Industries AG, Fuso Chemical Co., Ltd., Orthofix International NV, Polymers LLC, PolySciTech (Akina, Inc.), Resinex, Secant LLC, Sigma-Aldrich (Merck Group), and Synthecon Inc.

Polyglycerol Sebacate (PGS) Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 11
  • Tables & Figures: 182
  • Countries covered: 18
  • Pages: 200
 Download Free Sample